Key result
While neither polymorphism was associated with lipid levels overall, the ABCA1 I883M M allele was associated with lower HDL-C and higher LDL-C in patients with elevated ALT (P<0.05).
Why the study?
Are ABCA1 I883M and LPL HindIII gene polymorphisms associated with serum lipid levels in patients with hyperlipidemia?
Cross-Sectional (n=533)
Are ABCA1 I883M and LPL HindIII gene polymorphisms associated with serum lipid levels in patients with hyperlipidemia?
p-value: p=<.05
The ABCA1 I883M polymorphism interacts with elevated ALT levels to negatively impact HDL-C and LDL-C levels in hyperlipidemic patients.
May not yet guide lipid management in hyperlipidemia; leaves open ABCA1-ALT interaction on HDL-C/LDL-C for prospective study.
We conducted a cross-sectional study to investigate the effects of the adenosine triphosphate-binding cassette transporter 1 (ABCA1) I883M and lipoprotein lipase (LPL) HindIII polymorphisms on lipid levels in patients with hyperlipidemia. A total of 533 patients were enrolled. Serum lipid parameters were determined by an automatic biochemistry analyzer. Genotyping of the ABCA1 I883M and LPL HindIII was carried out using the polymerase chain reaction-restriction fragment length polymorphism technique. Multiple linear regression analysis was used to estimate the associations between serum lipid levels and the genetic polymorphisms. The frequency distribution of the ABCA1 I883M and LPL HindIII polymorphisms did not deviate from Hardy-Weinberg equilibrium. The major finding of our regression analysis showed that neither the ABCA1 I883M nor the LPL HindIII polymorphism was associated with baseline serum lipid levels in the total population. However, among patients with elevated alanine aminotransferase (ALT) levels (ALT ≥ 40 U/L), carriers of the M allele of the ABCA1 gene had lower levels of high-density lipoprotein cholesterol (HDL-C) and higher levels of low-density lipoprotein cholesterol (LDL-C) after adjusting for age, sex, smoking status, alcohol consumption, education level, occupation, and work intensity ( P < .05 for both). A test on interaction terms between the ABCA1 I833M polymorphism and ALT on HDL-C and LDL-C levels also remained significant ( P = .001 and P = .014, respectively). Our data suggest that there are significant interactive effects between ABCA1 I883M and ALT levels on HDL-C and LDL-C levels. However, the LPL HindIII polymorphism did not influence lipid levels.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2017) conducted a cross-sectional in Hyperlipidemia (n=533). ABCA1 I883M and LPL HindIII polymorphisms vs. Non-carriers / total population was evaluated on Baseline serum lipid levels (p=<.05). While neither polymorphism was associated with lipid levels overall, the ABCA1 I883M M allele was associated with lower HDL-C and higher LDL-C in patients with elevated ALT (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: